ESMO22 - Highlights prostaat- en blaaskanker

In deze podcast bespreken Koos van der Hoeven en Debbie Robbrecht onder andere de RADICALS-HD-studie, een studie waarin een indirecte vergelijking is gedaan van twee onderzoeken uit het STAMPEDE-platformprotocol, de PROpel-studie en een studie met de combinatie enfortumab vedotin met pembrolizumab bij gevorderd urotheelcarcinoom.

Episode metadata supplied by the publisher feed · Published Sep 16, 2022

Embed this episode

Attribution link and audio player

Ready to play

ESMO22 - Highlights prostaat- en blaaskanker

0:00 28:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncologie.nu?

This episode is 28 minutes long.

When was this Oncologie.nu episode published?

This episode was published on September 16, 2022.

Can I download this Oncologie.nu episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!